Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinye Li
Observed name:
X Li
Institution:
Flatiron Health (United States)
Observed institution:
Flatiron Health (United States)
ORCID:
0000-0002-6955-9748
Observed ORCID:
0000-0002-6955-9748
OpenAlex ID:
A5005607927
Impact of Real-World Response to First-Line Immunotherapy and Chemotherapy on Subsequent Treatment Outcomes in Patients With Advanced or Metastatic Non–Small Cell Lung Cancer
2026
·
Jyoti Malhotra
, Shilpa Viswanathan
, et al.
·
JCO Clinical Cancer Informatics
·
1
PP01.119: Real-World Clinical Outcomes in Second-line (2L) and Third-line (3L) Treatment for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the US: ESSENCE Study
2026
·
Helen Ross
, Tirza Areli Calderón Boyle
, et al.
·
Journal of Thoracic Oncology
RWD49 Bias Characterization of Real-World Patients With and Without Imaging in a Community Oncology Electronic Health Records Database
2022
·
X Li
, B Ackerman
, et al.
·
Value in Health
Show more works
View as search
Works count:
3
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type